• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Sustained drug delivery systems II: Factors affecting release rates from poly(epsilon-caprolactone) and related biodegradable polyesters.

作者信息

Pitt C G, Gratzl M M, Jeffcoat A R, Zweidinger R, Schindler A

出版信息

J Pharm Sci. 1979 Dec;68(12):1534-8. doi: 10.1002/jps.2600681219.

DOI:10.1002/jps.2600681219
PMID:529046
Abstract

The release rates of several steroids from films and capsules of homopolymers and copolymer of epsilon-caprolactone, DL-lactic acid, and glycolic acid were measured in vitro and in vivo for up to 200 days. Relatively constant release rates from capsules (reservoir devices) were observed only under certain conditions. Factors that influence the drug release kinetics were evaluated. Release from poly(epsilon-caprolactone) and poly(epsilon-caprolactone-co-DL-lactic acid) was diffusion controlled. Release from poly(DL-lactic acid-co-glycolic acid) was associated with polymer degradation. Release from poly(DL-lactic acid) was very slow when diffusion controlled.

摘要

相似文献

1
Sustained drug delivery systems II: Factors affecting release rates from poly(epsilon-caprolactone) and related biodegradable polyesters.
J Pharm Sci. 1979 Dec;68(12):1534-8. doi: 10.1002/jps.2600681219.
2
Sustained drug delivery systems. I. The permeability of poly(epsilon-caprolactone), poly(DL-lactic acid), and their copolymers.持续给药系统。I. 聚(ε-己内酯)、聚(DL-乳酸)及其共聚物的渗透性。
J Biomed Mater Res. 1979 May;13(3):497-507. doi: 10.1002/jbm.820130313.
3
In vitro evaluation of sustained drug release from biodegradable elastomer.可生物降解弹性体药物缓释的体外评价
Pharm Res. 1991 Oct;8(10):1292-6. doi: 10.1023/a:1015860030772.
4
Colchicine encapsulation within poly(ethylene glycol)-coated poly(lactic acid)/poly(epsilon-caprolactone) microspheres-controlled release studies.秋水仙碱包裹于聚乙二醇包覆的聚乳酸/聚己内酯微球中的控释研究。
Drug Deliv. 2000 Jul-Sep;7(3):129-38. doi: 10.1080/10717540050120160.
5
Controlled protein release from electrospun biodegradable fiber mesh composed of poly(epsilon-caprolactone) and poly(ethylene oxide).由聚(ε-己内酯)和聚(环氧乙烷)组成的电纺可生物降解纤维网的可控蛋白质释放。
Int J Pharm. 2007 Jun 29;338(1-2):276-83. doi: 10.1016/j.ijpharm.2007.01.040. Epub 2007 Feb 2.
6
Biodegradable polyesters for controlled release of trypanocidal drugs: in vitro and in vivo studies.用于锥虫病药物控释的可生物降解聚酯:体外和体内研究
Biomaterials. 1998 Oct;19(20):1827-37. doi: 10.1016/s0142-9612(98)00074-x.
7
The characterization of paclitaxel-loaded microspheres manufactured from blends of poly(lactic-co-glycolic acid) (PLGA) and low molecular weight diblock copolymers.由聚乳酸-乙醇酸共聚物(PLGA)与低分子量二嵌段共聚物的共混物制备的载紫杉醇微球的表征
Int J Pharm. 2007 Sep 5;342(1-2):6-17. doi: 10.1016/j.ijpharm.2007.04.022. Epub 2007 May 3.
8
Recent Advances in Application of Poly-Epsilon-Caprolactone and its Derivative Copolymers for Controlled Release of Anti-Tumor Drugs.聚ε-己内酯及其衍生物共聚物在抗肿瘤药物控释中的应用研究进展
Curr Cancer Drug Targets. 2017;17(5):445-455. doi: 10.2174/1568009617666170109150430.
9
Thermosensitive β-cyclodextrin modified poly(ε-caprolactone)-poly(ethylene glycol)-poly(ε-caprolactone) micelles prolong the anti-inflammatory effect of indomethacin following local injection.热敏β-环糊精修饰的聚(ε-己内酯)-聚乙二醇-聚(ε-己内酯)胶束经局部注射后延长了吲哚美辛的抗炎作用。
Acta Biomater. 2013 Jun;9(6):6953-63. doi: 10.1016/j.actbio.2013.02.005. Epub 2013 Feb 13.
10
Effect of the molecular weight of poly(epsilon-caprolactone-co-DL-lactide) on toremifene citrate release from copolymer/silica xerogel composites.
Int J Pharm. 2001 Jan 5;212(1):121-30. doi: 10.1016/s0378-5173(00)00601-3.

引用本文的文献

1
Immobilization of FGF on Poly(xylitol dodecanedioic Acid) Polymer for Tissue Regeneration.将 FGF 固定在聚(木糖醇十二烷二酸)聚合物上用于组织再生。
Sci Rep. 2020 Jun 26;10(1):10419. doi: 10.1038/s41598-020-67261-6.
2
Fabrication and characterization of electrospun poly(e-caprolactone) fibrous membrane with antibacterial functionality.具有抗菌功能的静电纺聚己内酯纤维膜的制备与表征
R Soc Open Sci. 2017 Feb 8;4(2):160911. doi: 10.1098/rsos.160911. eCollection 2017 Feb.
3
Controlled release of liraglutide using thermogelling polymers in treatment of diabetes.
利用温敏凝胶聚合物控制释放利拉鲁肽治疗糖尿病。
Sci Rep. 2016 Aug 17;6:31593. doi: 10.1038/srep31593.
4
Nanoparticles Based on Linear and Star-Shaped Poly(Ethylene Glycol)-Poly(ε-Caprolactone) Copolymers for the Delivery of Antitubulin Drug.基于线性和星形聚(乙二醇)-聚(ε-己内酯)共聚物的纳米颗粒用于抗微管蛋白药物递送
Pharm Res. 2016 Aug;33(8):2010-24. doi: 10.1007/s11095-016-1939-8. Epub 2016 May 13.
5
Macroscale delivery systems for molecular and cellular payloads.宏观递药系统用于分子和细胞有效载荷。
Nat Mater. 2013 Nov;12(11):1004-17. doi: 10.1038/nmat3758.
6
Materials and manufacturing technologies available for production of a pediatric bioabsorbable stent.用于生产儿科可吸收支架的材料和制造技术。
Biomed Res Int. 2013;2013:137985. doi: 10.1155/2013/137985. Epub 2013 Sep 8.
7
Functionalized hydrophobic poly(glycerol-co-ε-caprolactone) depots for controlled drug release.功能化疏水聚(甘油-co-ε-己内酯)储库用于控制药物释放。
Biomacromolecules. 2012 Feb 13;13(2):406-11. doi: 10.1021/bm201443m. Epub 2012 Feb 1.
8
Development and in vitro-in vivo evaluation of polymeric implants for continuous systemic delivery of curcumin.用于姜黄素持续全身递送的聚合物植入物的开发和体内外评价。
Pharm Res. 2011 May;28(5):1121-30. doi: 10.1007/s11095-011-0375-z. Epub 2011 Feb 11.
9
Intravascular tissue reactions induced by various types of bioabsorbable polymeric materials: correlation between the degradation profiles and corresponding tissue reactions.各种类型的可吸收聚合物材料引起的血管内组织反应:降解谱与相应组织反应之间的相关性。
Neuroradiology. 2010 Nov;52(11):1017-24. doi: 10.1007/s00234-010-0657-x. Epub 2010 Feb 10.
10
Modified paclitaxel-loaded nanoparticles for inhibition of hyperplasia in a rabbit arterial balloon injury model.用于抑制兔动脉球囊损伤模型中增生的改良紫杉醇负载纳米颗粒。
Pharm Res. 2007 May;24(5):955-62. doi: 10.1007/s11095-006-9214-z. Epub 2007 Mar 20.